Gyre Therapeutics (GYRE) Tax Rate (2010 - 2026)

Gyre Therapeutics (GYRE) has 8 years of Tax Rate data on file, last reported at 6.72% in Q1 2026.

• Tax Rate for Q1 2026 came in at 6.72%, down 2616.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 22.43% (up 3292.0% YoY), and the FY2025 annual result was 87.77%, down 52853.0% from the prior year.
• Tax Rate eased to 6.72% in Q1 2026 per GYRE's latest filing, from 6.6% in the prior quarter.
• Over five years, Tax Rate peaked at 35.6% in Q2 2023 and troughed at 22.36% in Q4 2022.
• A 5-year average of 14.83% and a median of 21.3% in 2024 frame the typical range for Tax Rate.
• The sharpest annual moves came in 2023 and 2026: Tax Rate soared 2166 bps in 2023, then sank 2616 bps in 2026.
• A 5-year view of Tax Rate shows it stood at 22.36% in 2022, then jumped by 97 bps to 0.7% in 2023, then sank by 37 bps to 0.96% in 2024, then slumped by 591 bps to 6.6% in 2025, then declined by 2 bps to 6.72% in 2026.
• Business Quant data shows GYRE's Tax Rate at 6.72% in Q1 2026, 6.6% in Q4 2025, and 22.19% in Q3 2025.